Trials / Completed
CompletedNCT04533256
Effects of Renal Replacement Therapy With Hemoadsoption in Patients With Sepsis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (actual)
- Sponsor
- Institutul Clinic Fundeni · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Hemoadsorption has been demonstrated to improve clinical and paraclinical results in critically ill patients with sepsis and septic shock. The present study investigates the effects of three consecutive sessions of hemoadsorption, performed in accordance to the local protocol for treating patients with sepsis, on organ failure, severity scores and 30-days mortality. Paraclinical results and severity scores were obtained before and after the three consecutive sessions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CytoSorb | three consecutive sessions of hemoadsorption in patients with sepsis |
Timeline
- Start date
- 2016-07-10
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
- First posted
- 2020-08-31
- Last updated
- 2021-09-13
Locations
1 site across 1 country: Romania
Source: ClinicalTrials.gov record NCT04533256. Inclusion in this directory is not an endorsement.